FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 307:7-13 July 1, 1982 Number 1 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We studied 58 recipients of bone-marrow transplants to evaluate immune responses to cytomegalovirus infection. Such infection developed in 43 patients; it was fatal in 12, nonfatal in 23, and present at death from other causes in eight. All patients had low or absent cytomegalovirus-specific cytotoxic lymphocyte activity before the onset of infection. Cytomegalovirus-specific cytotoxic responses developed in all survivors, whereas only two patients with fatal infection had even low-level cytomegalovirus-specific cytotoxic responses. Natural and antibody-dependent killer-cell activities were depressed both before and during infection in patients with fatal infections, but not in those who survived. The outcome of the infection did not correlate with the nature of the underlying disease, the type of transplant received, the pretransplantation cytomegalovirus-antibody status, or lymphocyte-proliferation responses to cytomegalovirus antigens or concanavalin A. The correlation between effective virus-specific cytotoxic response and recovery from infection indicates that these effector cells probably mediate recovery from cytomegalovirus infection.

This article has been cited by other articles:

• Crough, T., Khanna, R. (2009). Immunobiology of Human Cytomegalovirus: from Bench to Bedside. Clin. Microbiol. Rev. 22: 76-98 [Abstract] [Full Text]  
• Sacre, K., Nguyen, S., Deback, C., Carcelain, G., Vernant, J.-P., Leblond, V., Autran, B., Dhedin, N. (2008). Expansion of Human Cytomegalovirus (HCMV) Immediate-Early 1-Specific CD8+ T Cells and Control of HCMV Replication after Allogeneic Stem Cell Transplantation. J. Virol. 82: 10143-10152 [Abstract] [Full Text]  
• Gerna, G., Sarasini, A., Patrone, M., Percivalle, E., Fiorina, L., Campanini, G., Gallina, A., Baldanti, F., Revello, M. G. (2008). Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection. J. Gen. Virol. 89: 853-865 [Abstract] [Full Text]  
• Lilleri, D., Fornara, C., Chiesa, A., Caldera, D., Alessandrino, E. P., Gerna, G. (2008). Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection. haematol 93: 248-256 [Abstract] [Full Text]  
• Humphreys, I. R., Loewendorf, A., de Trez, C., Schneider, K., Benedict, C. A., Munks, M. W., Ware, C. F., Croft, M. (2007). OX40 Costimulation Promotes Persistence of Cytomegalovirus-Specific CD8 T Cells: A CD4-Dependent Mechanism. J. Immunol. 179: 2195-2202 [Abstract] [Full Text]  
• Lilleri, D., Gerna, G., Fornara, C., Lozza, L., Maccario, R., Locatelli, F. (2006). Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants. Blood 108: 1406-1412 [Abstract] [Full Text]  
• Trgovcich, J., Cebulla, C., Zimmerman, P., Sedmak, D. D. (2006). Human Cytomegalovirus Protein pp71 Disrupts Major Histocompatibility Complex Class I Cell Surface Expression. J. Virol. 80: 951-963 [Abstract] [Full Text]  
• Chalandon, Y., Degermann, S., Villard, J., Arlettaz, L., Kaiser, L., Vischer, S., Walter, S., Heemskerk, M. H. M., van Lier, R. A. W., Helg, C., Chapuis, B., Roosnek, E. (2006). Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications. Blood 107: 389-396 [Abstract] [Full Text]  
• Perreau, M., Kremer, E. J. (2005). Frequency, Proliferation, and Activation of Human Memory T Cells Induced by a Nonhuman Adenovirus. J. Virol. 79: 14595-14605 [Abstract] [Full Text]  
• Bunde, T., Kirchner, A., Hoffmeister, B., Habedank, D., Hetzer, R., Cherepnev, G., Proesch, S., Reinke, P., Volk, H.-D., Lehmkuhl, H., Kern, F. (2005). Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. JEM 201: 1031-1036 [Abstract] [Full Text]  
• Trivedi, D., Williams, R. Y., O'Reilly, R. J., Koehne, G. (2005). Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy. Blood 105: 2793-2801 [Abstract] [Full Text]  
• Manley, T. J., Luy, L., Jones, T., Boeckh, M., Mutimer, H., Riddell, S. R. (2004). Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection. Blood 104: 1075-1082 [Abstract] [Full Text]  
• Hakki, M., Riddell, S. R., Storek, J., Carter, R. A., Stevens-Ayers, T., Sudour, P., White, K., Corey, L., Boeckh, M. (2003). Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation. Blood 102: 3060-3067 [Abstract] [Full Text]  
• Meijer, E., Boland, G. J., Verdonck, L. F. (2003). Prevention of Cytomegalovirus Disease in Recipients of Allogeneic Stem Cell Transplants. Clin. Microbiol. Rev. 16: 647-657 [Abstract] [Full Text]  
• Papanicolaou, G. A., Latouche, J.-B., Tan, C., Dupont, J., Stiles, J., Pamer, E. G., Sadelain, M. (2003). Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele. Blood 102: 2498-2505 [Abstract] [Full Text]  
• Shen, X., Wong, S. B. J., Buck, C. B., Zhang, J., Siliciano, R. F. (2002). Direct Priming and Cross-Priming Contribute Differentially to the Induction of CD8+ CTL Following Exposure to Vaccinia Virus Via Different Routes. J. Immunol. 169: 4222-4229 [Abstract] [Full Text]  
• Le Roy, E., Baron, M., Faigle, W., Clement, D., Lewinsohn, D. M., Streblow, D. N., Nelson, J. A., Amigorena, S., Davignon, J.-L. (2002). Infection of APC by Human Cytomegalovirus Controlled Through Recognition of Endogenous Nuclear Immediate Early Protein 1 by Specific CD4+ T Lymphocytes. J. Immunol. 169: 1293-1301 [Abstract] [Full Text]  
• Einsele, H., Roosnek, E., Rufer, N., Sinzger, C., Riegler, S., Loffler, J., Grigoleit, U., Moris, A., Rammensee, H.-G., Kanz, L., Kleihauer, A., Frank, F., Jahn, G., Hebart, H. (2002). Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 99: 3916-3922 [Abstract] [Full Text]  
• Junghanss, C., Boeckh, M., Carter, R. A., Sandmaier, B. M., Maris, M. B., Maloney, D. G., Chauncey, T., McSweeney, P. A., Little, M.-T., Corey, L., Storb, R. (2002). Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study. Blood 99: 1978-1985 [Abstract] [Full Text]  
• Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M., Munz, C. (2002). Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells. JEM 195: 343-351 [Abstract] [Full Text]  
• Pepperl, S., Münster, J., Mach, M., Harris, J. R., Plachter, B. (2000). Dense Bodies of Human Cytomegalovirus Induce both Humoral and Cellular Immune Responses in the Absence of Viral Gene Expression. J. Virol. 74: 6132-6146 [Abstract] [Full Text]  
• Cheeran, M. C.-J., Hu, S., Gekker, G., Lokensgard, J. R. (2000). Decreased Cytomegalovirus Expression Following Proinflammatory Cytokine Treatment of Primary Human Astrocytes. J. Immunol. 164: 926-933 [Abstract] [Full Text]  
• Sia, I. G., Patel, R. (2000). New Strategies for Prevention and Therapy of Cytomegalovirus Infection and Disease in Solid-Organ Transplant Recipients. Clin. Microbiol. Rev. 13: 83-121 [Abstract] [Full Text]  
• Zaia, J. A., Sissons, J.G. P., Riddell, S., Diamond, D. J., Wills, M.R., Carmichael, A.J., Weekes, M.P., Gandhi, M., La Rosa, C., Villacres, M., Lacey, S., Markel, S., Sun, J. (2000). Status of Cytomegalovirus Prevention and Treatment in 2000. ASH Education Book 2000: 339-355 [Abstract] [Full Text]  
• Gosselin, J., TomoIu, A., Gallo, R. C., Flamand, L. (1999). Interleukin-15 as an Activator of Natural Killer Cell-Mediated Antiviral Response. Blood 94: 4210-4219 [Abstract] [Full Text]  
• Solache, A., Morgan, C. L., Dodi, A. I., Morte, C., Scott, I., Baboonian, C., Zal, B., Goldman, J., Grundy, J. E., Madrigal, J. A. (1999). Identification of Three HLA-A*0201-Restricted Cytotoxic T Cell Epitopes in the Cytomegalovirus Protein pp65 That Are Conserved Between Eight Strains of the Virus. J. Immunol. 163: 5512-5518 [Abstract] [Full Text]  
• Kern, F., Surel, I. P., Faulhaber, N., Frommel, C., Schneider-Mergener, J., Schonemann, C., Reinke, P., Volk, H.-D. (1999). Target Structures of the CD8+-T-Cell Response to Human Cytomegalovirus: the 72-Kilodalton Major Immediate-Early Protein Revisited. J. Virol. 73: 8179-8184 [Abstract] [Full Text]  
• Morello, C. S., Cranmer, L. D., Spector, D. H. (1999). In Vivo Replication, Latency, and Immunogenicity of Murine Cytomegalovirus Mutants with Deletions in the M83 and M84 Genes, the Putative Homologs of Human Cytomegalovirus pp65 (UL83). J. Virol. 73: 7678-7693 [Abstract] [Full Text]  
• Le Roy, E., Mühlethaler-Mottet, A., Davrinche, C., Mach, B., Davignon, J.-L. (1999). Escape of Human Cytomegalovirus from HLA-DR-Restricted CD4+ T-Cell Response Is Mediated by Repression of Gamma Interferon-Induced Class II Transactivator Expression. J. Virol. 73: 6582-6589 [Abstract] [Full Text]  
• Fletcher, J. M., Prentice, H. G., Grundy, J. E. (1998). Natural Killer Cell Lysis of Cytomegalovirus (CMV)-Infected Cells Correlates with Virally Induced Changes in Cell Surface Lymphocyte Function-Associated Antigen-3 (LFA-3) Expression and Not with the CMV-Induced Down-Regulation of Cell Surface Class I HLA. J. Immunol. 161: 2365-2374 [Abstract] [Full Text]  
• Mattapallil, J. J., Smit-McBride, Z., McChesney, M., Dandekar, S. (1998). Intestinal Intraepithelial Lymphocytes Are Primed for Gamma Interferon and MIP-1beta Expression and Display Antiviral Cytotoxic Activity despite Severe CD4+ T-Cell Depletion in Primary Simian Immunodeficiency Virus Infection. J. Virol. 72: 6421-6429 [Abstract] [Full Text]  
• Steffens, H.-P., Kurz, S., Holtappels, R., Reddehase, M. J. (1998). Preemptive CD8 T-Cell Immunotherapy of Acute Cytomegalovirus Infection Prevents Lethal Disease, Limits the Burden of Latent Viral Genomes, and Reduces the Risk of Virus Recurrence. J. Virol. 72: 1797-1804 [Abstract] [Full Text]  
• Matano, T., Shibata, R., Siemon, C., Connors, M., Lane, H. C., Martin, M. A. (1998). Administration of an Anti-CD8 Monoclonal Antibody Interferes with the Clearance of Chimeric Simian/Human Immunodeficiency Virus during Primary Infections of Rhesus Macaques. J. Virol. 72: 164-169 [Abstract] [Full Text]  
• MacDonald, M. R., Li, X.-Y., Stenberg, R. M., Campbell, A. E., Virgin, H. W. IV (1998). Mucosal and Parenteral Vaccination against Acute and Latent Murine Cytomegalovirus (MCMV) Infection by Using an Attenuated MCMV Mutant. J. Virol. 72: 442-451 [Abstract] [Full Text]  
• Wijdicks, E. F. M., Borel, C. O. (1998). Respiratory management in acute neurologic illness. Neurology 50: 11-20 [Full Text]  
• Diamond, D. J., York, J., Sun, J.-Y., Wright, C. L., Forman, S. J. (1997). Development of a Candidate HLA A*0201 Restricted Peptide-Based Vaccine Against Human Cytomegalovirus Infection. Blood 90: 1751-1767 [Abstract] [Full Text]  
• Younger, D. S., Worrall, B. B., Penn, A. S. (1997). Myasthenia gravis: Historical perspective and overview. Neurology 48: 1S-7S [Full Text]  
• Liu, C.-C., Young, L. H.Y., Young, J. D.-E (1996). Lymphocyte-Mediated Cytolysis and Disease. NEJM 335: 1651-1659 [Full Text]  
• Walter, E. A., Greenberg, P. D., Gilbert, M. J., Finch, R. J., Watanabe, K. S., Thomas, E. D., Riddell, S. R. (1995). Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor. NEJM 333: 1038-1044 [Abstract] [Full Text]  
• Orentas, R., Hildreth, J., Obah, E, Polydefkis, M, Smith, G., Clements, M., Siliciano, R. (1990). Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine. Science 248: 1234-1237 [Abstract]  
• Walker, C., Moody, D., Stites, D., Levy, J. (1986). CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234: 1563-1566 [Abstract]